<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04820231</url>
  </required_header>
  <id_info>
    <org_study_id>191</org_study_id>
    <nct_id>NCT04820231</nct_id>
  </id_info>
  <brief_title>Platelet-Rich Plasma and Hip Osteoarthritis</brief_title>
  <official_title>The Effect of Platelet-Rich Plasma Injection on Pain, Function and Quality of Life in Patients With Hip Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of platelet-rich plasma (PRP) injection on pain, function and quality&#xD;
      of life in patients with hip osteoarthritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and potential risk, all patients giving written informed&#xD;
      consent will undergo study entry.&#xD;
&#xD;
      Each patient received three times intra-articuler injections of PRP under ultrasound&#xD;
      guidance, and they were administered once a week.&#xD;
&#xD;
      Baseline: Visual Analog Scale (VAS) including movement, rest and night, the Western Ontario&#xD;
      and McMaster University Osteoarthritis Index (WOMAC) and SF-36 assessment&#xD;
&#xD;
      1st month: VAS, WOMAC and SF-36 assessment&#xD;
&#xD;
      3rd month: VAS, WOMAC and SF-36 assessment&#xD;
&#xD;
      6th month: VAS, WOMAC and SF-36 assessment&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The patients with mono-lateral hip pain , grade 1 or 2 hip osteoarthritis according to the Kellgren-Lawrence classification</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Visual Analog Scale (VAS) score at 1-month, 3-month and 6-month</measure>
    <time_frame>Baseline, 1st month, 3rd month, 6th month</time_frame>
    <description>The VAS is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 'no pain' and 'worst pain'.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline Western Ontario and McMaster University Osteoarthritis Index (WOMAC) score at 1-month, 3-month and 6-month</measure>
    <time_frame>Baseline, 1st month, 3rd month, 6th month</time_frame>
    <description>The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a total WOMAC score, however there are other methods that have been used to combine scores.&#xD;
Higher scores: worse pain, stiffness, and functional limitations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline SF-36 score at 1-month, 3-month and 6-month</measure>
    <time_frame>Baseline, 1st month, 3rd month, 6th month</time_frame>
    <description>The SF-36 is a 36-item self-report measure of health-related quality of life. It has eight subscales measuring different domains of health-related quality of life: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health . Two component scores are derived from the eight subscales: a physical health component score and a mental health component score.&#xD;
High scores: good quality of life</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>PRP injection group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intra-articular PRP injection with ultrasound guidance&#xD;
Three times PRP injections with an interval of one week</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intra-articular PRP injection</intervention_name>
    <arm_group_label>PRP injection group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hip pain VAS &gt; 4&#xD;
&#xD;
          -  Grade 1 and 2 osteoarthritis according to the Kellgren-Lawrence classification&#xD;
&#xD;
          -  No pathologies in the laboratory and coagulation parameters&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rheumatological disease with hip involvement&#xD;
&#xD;
          -  Systemic active infection&#xD;
&#xD;
          -  Severe cardiovascular disease&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  NSAID usage in the last week&#xD;
&#xD;
          -  History of hip joint surgery&#xD;
&#xD;
          -  History of traumatic hip injury&#xD;
&#xD;
          -  Hgb values &lt; 11 gr/dl&#xD;
&#xD;
          -  Platelets values &lt; 150.000 / µl&#xD;
&#xD;
          -  History of bleeding disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jülide Öncü Alptekin</last_name>
    <role>Study Chair</role>
    <affiliation>Şişli Hamidiye Etfal Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Şişli Hamidiye Etfal Training and Research Hospital</name>
      <address>
        <city>İstanbul</city>
        <state>Şişli</state>
        <zip>34371</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Selda Çiftci</investigator_full_name>
    <investigator_title>Specialist, Principal investigator</investigator_title>
  </responsible_party>
  <keyword>hip osteoarthritis</keyword>
  <keyword>platelet-rich plasma</keyword>
  <keyword>ultrasound guidance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

